Posted in

Pharmacotherapy And Translational Research News

How Low Can You Go?

For patients with diabetes and heart disease, less isn’t always more — at least when it comes to blood pressure. New data show an increased risk of heart attack, stroke or death for patients having blood pressure deemed too high — or  too low, according to Rhonda Cooper-DeHoff, Pharm.D., an associate professor of pharmacy and medicine at UF. She reported her findings in March at the American College of Cardiology’s 59th annual scientific session in Atlanta. She recommends raising the systolic bar above 120 for blood pressure in patients with diabetes and coronary artery disease, saying that levels between 130 and 140 appear to be the most healthful.

On Call: MTM Call Center Helps Patients Manage Prescriptions

Imagine sitting in your den, chatting with your pharmacist over a cup of coffee. For one uninterrupted hour it’s just you, your prescription medications and your pharmacist — answering your questions. In a partnership with national health plan company WellCare Health Plans, Inc., the UF College of Pharmacy is receiving $2.5 million to establish a Medication Therapy Management Call Center. The call center satisfies a government requirement for health-plan providers of the Medicare prescription drug benefit to provide once a year comprehensive medication review with quarterly follow ups, called Medication Therapy Management (MTM).

Pharmacogenomic Researcher Awarded $10.6M

A University of Florida genetics researcher has received $10.6 million to further a national effort to use genetic data to more effectively pinpoint which medications and treatments are best for individual patients. Julie A. Johnson, Pharm.D., the V. Ravi Chandran Professor in Pharmaceutical Sciences and chair of pharmacotherapy and translational research in the College of Pharmacy, is one of 14 researchers who have received a five-year award as part of the National Institute of Health’s Pharmacogenomics Research Network.